🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢 LETTER TO THE EDITOR 👉 Portuguese #osteoporosis screening in the community: what did we learn? by Oliveira D et al 🔗 arprheumatology.com/section.php?id… ✅ 767 individuals ✅ 73.9% female ✅ Mean T score -1.26±1.15[-5.30-2.20] ✅ Mean Z score-0.92±0.50[-3.20-1.90]

📣 The ARP is now on LinkedIn! Follow us to stay updated on the latest news in the world of Rheumatology. 🌐 linkedin.com/in/arp-rheumat…

🚀 ONLINE FIRST 🔗 arprheumatology.com/article_abstra… #MCTD #Myositis #Rheumatology #AutoimmuneDisease #HealthcareResearch #ARPRheumatology

🚀 ONLINE FIRST 🔗 arprheumatology.com/article_abstra… #Osteoarthritis #MentalHealth #PainManagement #ARPRheumatology

🚨 New Review on Axial Spondyloarthritis and Gut Microbiota! 🚨 🔗 Read more: arprheumatology.com/article_abstra… #Rheumatology #GutHealth #Spondyloarthritis #Microbiota #AutoimmuneResearch #HealthInnovation

🌍 Today is #WorldArthritisDay! We raise awareness about the importance of early diagnosis, effective treatment, and a strong patient-healthcare professional partnership. 💙 Let’s continue to support research, promote better care, and work towards a pain-free future!

📑 Original Article 🌐 Read more: arprheumatology.com/section.php?id…

Access the full recommendations here: arprheumatology.com/section.php?id… Daniela Faria Alessia Alunno Lovro Lamot EUSTAR EMEUNET Ana Maria Rodrigues Pedro Machado Global Scleroderma Initiative @scleroderma SRUK | Scleroderma & Raynaud's UK MOScleroderma Scleroderma Canada Scleroderma EULAR HPR - Health Professionals in Rheumatology EULAR

➡Better Care for Axial SpA Patients! Did you know education can be as powerful as exercise in managing axial spondyloarthritis (axSpA)? #AxSpA #PatientEducation #Spondyloarthritis #HealthcareInnovation 🌐Read more: arprheumatology.com/article_abstra…

Did you know 8.7% of #psoriasis patients also have psoriatic arthritis (PsA)? Early detection is key! Dermatologists can spot PsA before joint symptoms begin using tools like the EARP-PT questionnaire, which helps flag PsA risks with ease. 🌐Read more: arprheumatology.com/article_abstra…

A new meta-analysis shows no significant difference between supervised and non-supervised exercises in improving pain and function for knee osteoarthritis patients. 🌐 Read more: arprheumatology.com/article_abstra… #Knee #Osteoarthritis #ExerciseScience #systematicreview #arprheumatology

⚠️ Unlike tuberculosis, nontuberculous mycobacteria (NTM) infections lack pre-screening protocols, underscoring the importance of vigilant monitoring in immunosuppressed patients. 🌐 Read more: arprheumatology.com/article_abstra… #ImmunosuppressiveTherapy #SystemicLupusErythematosus

💡 A recent study demonstrates that Ab501 (certolizumab equivalent) effectively controls #inflammation and prevents bone loss in a rheumatoid arthritis mouse model. 🌐 Read more: arprheumatology.com/article_abstra… #ArthritisResearch #BoneHealth #RheumatoidArthritis #ARPRheumatology

🧪 Biomarkers Predict Kidney Damage in Lupus (SLE) This study found IL-17, IL-23 & IL-10 levels were significantly elevated in SLE—especially in severe lupus nephritis (class III/IV). Read more: arprheumatology.com/article_abstra…

A cross-sectional study in Portugal found limited implementation of 2024 EULAR/PreS recommendations for #StillDisease. arprheumatology.com/article_abstra…

🫁This nationwide study analyzed over 1 million hospitalizations and found both #CTD-ILD and IIP patients faced significantly higher mortality than those without ILD. ⚠️ Full article 👉 arprheumatology.com/article_abstra…

💊 How well are patients with rheumatic diseases being educated about #methotrexate? A survey across 26 European countries (n=2316) explored the experiences of patients/carers, nurses, and physicians about MTX education and access to #nurse care. 🔗 :arprheumatology.com/article_abstra…

📢 new issue: 🔍 AI & critical thinking in medical research 🧪 Interleukin biomarkers in lupus nephritis 🌍 MTX patient education 26 countries 🦠 COVID-19 & CTD-ILD 🩺 Rare vasculitis, PMR treatment challenges 🌐 Culturally adapted tools for SSc & FM 🔗 arprheumatology.com/archive_detail…

👏 Huge thanks to Professor Alexandre Sepriano for his outstanding service as Editor-in-Chief of ARP Rheumatology! 👏 Under his leadership, the journal expanded internationally, changed its name, adopted English only, and streamlined submissions — boosting quality and impact.

✨The 2024 IF for ARP Rheumatology is 1.4! 📈 Our first total IF under the new name keeps the growth from 1.375 in 2022, securing a solid Q3 position. 🙏 Thank you to our authors, reviewers, Associate Editors & community for making this possible — and here’s to more growth ahead!